Jan 12, 2000
Guidant Announces Market Release of Next Generation Pacemaker Systems in Europe
Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in cardiac rhythm management systems, today announced the European market release of the next generation in pacemaker devices -- the PULSAR(tm) MAX II blended-sensor pacemaker system and the DISCOVERY(tm) II single-sensor system. "The PULSAR MAX II and DISCOVERY II devices provide the world''s first pacemaker systems with a unique combination of features to manage abnormal heart rates in the heart''s upper chambers and provide unmatched stored electrogram quality," noted Jay Graf, president of Guidant''s Cardiac Rhythm Management Group. "We believe it provides solutions never before available to physicians faced with the challenge of treating pacemaker patients who also have atrial fibrillation." The PULSAR MAX II and DISCOVERY II devices introduce new features designed to help physicians manage patients with atrial arrhythmias. These features are intended to: The PULSAR MAX II also has a sophisticated algorithm designed to provide an appropriate heart rate for a patient''s given level of activity. The device''s proprietary blended sensor capability is designed to measure patient motion and a patient''s respiration rate to optimize device therapy for the patient. The PULSAR MAX II and DISCOVERY II devices include Guidant''s ease-of-use features that allow the clinician to easily and quickly perform a comprehensive set of automatic tests and follow-up operations. The result is one concise report that summarizes data needed for informed patient management. Guidant was the fastest growing pacemaker supplier in Europe in 1999. A global leader in the medical device industry, Guidant provides innovative, minimally invasive and cost-effective products and services for the treatment of cardiovascular and vascular disease. For more information on Guidant''s products and services, visit the company''s web site at http://www.guidant.com.